The slip
PARKINSON RECEIPTno. 5605
21 Oct 2026, 18:47 UTCdopamine neurons, braak
predictionRAB8A in dopamine neurons tracks Braak Lewy-body stage
registeredcdd78d165d0b5bb4
discovery-0.11 p=0.784 n=9
replication-0.06 p=0.888 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.11, p 0.784)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8855b2aa16ac5367adcfe6da…
follows 351ed2ba1a6e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 5605: RAB8A in dopamine neurons, braak
- power
- full sample -0.03 (p 0.894, n 18), 95% CI -0.49 to +0.44. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.894, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.02 (p 0.928, n 18). could be the mix.
- skeptic
- leave-one-out range -0.16 to +0.09, sign flips 6; without severely affected donors -0.03 (p 0.894, n 18). fragile.
- cell type
- strongest in microglia: -0.71 (p 9.1e-4, n 18) vs -0.03 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RAB8A in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up RAB8A · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.00 p 1.000 (needs p < 3.6e-4)